By PTI
The trials, which will commence in December, will be conducted on 250 patients across 20-25 centres in India, according to the filing.
By FPJ Web Desk
Prime Minister Narendra Modi was on his three-city visit on Saturday to review coronavirus vaccine development work. Three major pharma p...Read More
By ANI
"The scientists, all 18,000 of them and 25,000 plus Ziduns are continuously thriving and working for providing safe and efficacious vacci...Read More
By FPJ Web Desk
In India, top contenders are Covishield, Covaxin and ZyCov-D. And, there is a new hope that India can get a vaccine soon. But, who will s...Read More
By PTI
India's apex medical body ICMR said Friday that it aims to launch the world's first COVID-19 vaccine, the indigenously developed Covaxin,...Read More
By ANI
Ahmedabad: Healthcare major Zydus Cadila said on Friday its plasmid DNA vaccine candidate for COVID-19 (ZyCoV-D) developed indigenously a...Read More
By FPJ Web Desk
Dr. Reddy's Laboratories has entered into a non-exclusive licensing agreement with American-based biopharmaceutical company, Gilead Scien...Read More
By FPJ Web Desk
India is the biggest manufacturer of hydroxychloroquine, the anti-malarial drug that is being touted as 'game-changer' in the fight again...Read More
By FPJ Bureau
New Delhi : Zydus Cadila group firm Cadila Healthcare reported a 10.93 % rise in net profit to Rs 388.7 crore for the March quarter and a...Read More
By FPJ Bureau
New Delhi : Zydus Cadila has expanded its animal health business with the acquisition of some select brands and a Haridwar-based manufact...Read More
By FPJ Bureau
New Delhi : Drug firm Zydus Cadila today launched biosimilar of Adalimumab, used for treatment of auto immune disorders, at a price much ...Read More